Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
The company reports revenue growth of 26% and PAT growth of 21% YoY
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The new platform is the latest initiative under Lupin’s long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailment
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
For undertaking production, the company has been provided a Rs. 65 crore grant by the centre and Rs. 94 crore from the government of Maharashtra
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
PEL will explore the PLI scheme and apply if its beneficial.
The company is expecting tremendous growth and a better quarterly performance
Subscribe To Our Newsletter & Stay Updated
